Clinical trial
Post-cesarean Section Analgesic Potency and Side Effects of Intrathecal Morphine and Nalbuphine
NCT02716129 is registered in ClinicalTrials.gov with Abdelrady S Ibrahim, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-cesarean Section Analgesic Potency and Side Effects of Intrathecal Morphine and Nalbuphine
- Lead sponsor
- Abdelrady S Ibrahim, MD
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2016
- Completion date
- October 31, 2017
- Enrollment
- 80 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.